Ppmi 2.0 Clinical -Establishing A Deeply Phenotyped Pd Cohort
Posted Date: Apr 30, 2021
- Investigator: Alberto Espay
- Specialties: Movement Disorders, Neurology, Parkinson's Disease
- Type of Study: Observational/Survey
The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls. The overall goal of PPMI 2.0 is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.
Parkinson's Disease, Neurology, Espay
For More Information: